An interventional study of Early Start Denver Model (ESDM) in Autism Spectrum Disorder, sponsored by University Hospital, Montpellier. Recruiting at 1 site in France. Open to participants aged 2 Years to 5 Years. Per ClinicalTrials.gov, last updated 2023-11-13.
Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Autism Spectrum Disorder by University Hospital, Montpellier — 5 open to participants now, 6 under way, none of them phase 3. Autism Spectrum Disorder · University Hospital, Montpellier.
Among the 12 studies in Autism Spectrum Disorder by University Hospital, Montpellier, this one is one of 3 that started in 2023, is one of 6 with no phase, and was the 11th registered.
1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.
Browse Autism Spectrum Disorder studies →5 of the 12 studies in Autism Spectrum Disorder by University Hospital, Montpellier are open now, in 1 country. Recruiting first, the newest first:
University Hospital, Montpellier · Sites in France
Ages 1–16 · Healthy volunteers
University Hospital, Montpellier · Sites in France
Ages 2–16
University Hospital, Montpellier · Sites in France
Healthy volunteers
University Hospital, Montpellier · Sites in France
Ages 6–16
By country, each count listing its studies:
Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.
This study: 2 Years to 5 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 3 started in 2023.
This study's planned enrollment of 8 is below the median of 52 across 1,374 interventional studies indexed under Autism Spectrum Disorder.
Median enrollment 62 across the 6 interventional studies, 752 across the 6 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Hospital, Montpellier is the lead sponsor of 1,264 studies on the registry; 226 are open to participants now.
1 of the studies in Autism Spectrum Disorder by University Hospital, Montpellier that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05512637University Hospital, MontpellierScreening for Neurodevelopmental Disorders in Siblings of Children With Autism Diagnosed in Tertiary Centers | 2026-11 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Autism Spectrum Disorder by University Hospital, Montpellier, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
For several years, studies have been developed on the contribution of social robots as a tool for interventions for children with autism spectrum disorders (ASD). One of the recommended intervention models is the ESDM (Early Start Denver Model). It consists of setting up an individualized, intensive program (at least 20 hours per week) through the pleasure of play. The teacher follows the motivation and interests of the child, and it is the child who chooses the activities. Studies published in recent years tend to show that robots bring benefits to ASD children, particularly in the treatment of social interactions and in clinical settings. However, there is no scientific consensus on the generalized contribution and effect over time of these interventions. Moreover, a robotic solution controlled by a practitioner through a telepresence system allows for a better adaptability to the responses and desires of the children during the interventions. The investigators believe that such a solution would allow for better assessment of progress in the core skills of expressive communication and imitation and greater engagement during interventions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients
Therapist
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Early Start Denver Model (ESDM)
Phase A * 4 individual sessions (1 per week) * Additional time of 15 minutes to evaluate 3 selected tasks of the ESDM * Satisfaction Evaluation - Parent * Satisfaction Evaluation - Therapist Phase B : * 11 sessions (1 per week) * Additional time of 15 minutes to evaluate 3 selected tasks of the ESDM with the help of the robot Pepper * Satisfaction Evaluation - Parent * Satisfaction Evaluation - Therapist Phase C : * 4 sessions (1 per week) * Additional time of 15 minutes to evaluate 3 selected tasks of the ESDM without the help of the robot Pepper * Satisfaction Evaluation - Parent * Satisfaction Evaluation - Therapist * All sessions will also be filmed and recorded
Score of success on the selected task in the ESDM program
Measure the success score for the selected task using the ESDM scoring grid. As soon as the child successfully completes one of the different learning stages, a success score is given to the task. This score will be maximum if all the learning stages of the task considered have been reached (Task 1 = 6 learning stages (maximum score =6); Tasks 2 and 3 = 7 stages (maximum score =7)). The ESDM scoring grid will be completed by the research therapists at the end of each session.
Time frame: From phase A (baseline) to phase C (post-intervention) = 19 weeks
Time of the child's viewing and movement of the head and body towards the robot (task 1: saying "hello")
Measurement of the viewing and movement times toward the robot, as well as the response time from the analysis of the videos made during the sessions using the Pepper robot. Data from the robot: - Video recording by camera of the sessions of the whole room (camera independent of the robot) - Video return by the camera installed on the robot - Audio feedback from the therapist, the robot and the child.
Time frame: During Phase B = 11 weeks
Time of the child's viewing and movement of the head and body towards the therapist (task 1: saying "hello")
Measurement of the viewing and movement times toward the therapist, as well as the response time from the analysis of the videos made during the sessions using the Pepper robot. Data from the robot: - Video recording by camera of the sessions of the whole room (camera independent of the robot) - Video return by the camera installed on the robot - Audio feedback from the therapist, the robot and the child.
Time frame: From phase A (baseline) to phase C (post-intervention) = 19 weeks
Response time of the child after the presentation of the imitation exercise (task 2: action imitation)
Measurement of the child's response time during the imitation exercise
Time frame: From phase A (baseline) to phase C (post-intervention) = 19 weeks
Number of objects given to the robot (task 3 : give an object on verbal request)
Measurement of the number of objects given out of the 5 requested (best score 5/5) in task 3.
Time frame: From phase A (baseline) to phase C (post-intervention) = 19 weeks
Teleoperation success score for therapist (throught UX score)
Measurement of the success score (UX) of the teleoperation using the videos of the Pepper robot and according to the successful tasks to be performed during the session (the child and the second practitioner in the room can clearly hear the robot's instructions, the robot's gestures are fluid and is able to point to objects with the hand...). If the therapist was able to initiate each task, the score is 3/3.
Time frame: Phase C (from week 5 to 15)
Parent satisfaction score on current care
Measurement of satisfaction score using a numerical satisfaction scale (EN). Parents will be asked about their current satisfaction with the care after each phase of the procedure. This will be rated on a scale of 0 to 10, (0 "I am not at all satisfied with the effectiveness of the proposed care" and 10 "I am totally satisfied with the care").
Time frame: During phase A (to 4 weeks), Phase B (to 15 weeks), Phase C (to 19 weeks).
Professional satisfaction score on current care.
Measurement of satisfaction score using a numerical satisfaction scale (EN). Professionals will be asked about their current satisfaction with the care after each phase of the procedure. This will be rated on a scale of 0 to 10, (0 "I am not at all satisfied with the effectiveness of the proposed care" and 10 "I am totally satisfied with the care").
Time frame: During phase A (to 4 weeks), Phase B (to 15 weeks), Phase C (to 19 weeks)
Score of success in the ESDM tasks without teleoperation
This score (observe/total) will be maximum if all the learning stages of the task in question have been reached (Task 1 = 6 learning stages (maximum score =6); Tasks 2 and 3 = 7 stages (maximum score = 7)). This scoring will be done by therapist at the end of each intervention, after the current care.
Time frame: During phase A (to 4 weeks), Phase C (from week 16 to 19
Score of success in the ESDM tasks with teleoperation
This score (observe/total) will be maximum if all the learning stages of the task in question have been reached (Task 1 = 6 learning stages (maximum score =6); Tasks 2 and 3 = 7 stages (maximum score =7)).The robotics analyses will be performed by a robotic engineer of the LIRMM independent to the project.
Time frame: During phase B (from week 5 to 15)
Teleoperation usability score for therapist (throught UMUX score)
A User Experience Questionnaire (UMUX) was administered at weeks 5, 10 and 15 to assess the quality and ease of use of the teleoperation system over time. The questionnaires are evaluated on a scale from 0 (minimum score) to 10 (maximum score). 0=Not at all satisfied 10= Totally satisfied
Time frame: During phase A (to 4 weeks), Phase B (to 15 weeks), Phase C (to 19 weeks)
Started Oct 2023 (actual). Primary completion is estimated for Mar 2025, 17 months after the start.
Of 806 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 17 months is below that.
Counting every sponsor, half of 829 studies reached it within 25 months; a quarter within 12 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Montpellier →